Matrix Metalloproteinase-9 Is a Marker of Heart Failure After Acute Myocardial Infarction
- 1 February 2006
- journal article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 12 (1) , 66-72
- https://doi.org/10.1016/j.cardfail.2005.08.002
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Near-Infrared Fluorescent Imaging of Matrix Metalloproteinase Activity After Myocardial InfarctionCirculation, 2005
- Overexpression of Brain Natriuretic Peptide Facilitates Neutrophil Infiltration and Cardiac Matrix Metalloproteinase-9 Expression After Acute Myocardial InfarctionCirculation, 2004
- Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures - The Framingham Heart StudyCirculation, 2004
- Predictors of late development of heart failure in stable survivors of myocardial infarctionJournal of the American College of Cardiology, 2003
- Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)Circulation, 2003
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Matrix Metalloproteinase Inhibition After Myocardial InfarctionCirculation Research, 2001
- Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial InfarctionCirculation, 1996
- Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.Circulation, 1990
- Early estimation of risk by echocardiographic determination of wall motion index in an unselected population with acute myocardial infarctionThe American Journal of Cardiology, 1990